9PUB | pdb_00009pub

Biotin-streptavidin binding

  • Classification: PROTEIN BINDING
  • Organism(s): Streptomyces avidinii
  • Mutation(s): No 

  • Deposited: 2025-07-30 Released: 2025-09-03 
  • Deposition Author(s): Whitby, F.G.
  • Funding Organization(s): National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 0.95 Å
  • R-Value Free: 
    0.145 (Depositor), 0.146 (DCC) 
  • R-Value Work: 
    0.131 (Depositor), 0.132 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history


Literature

Protein chirality as a determinant of ligand affinity: insights from l- and d-streptavidin.

Giesler, R.J.Woodham, P.C.S.Draper, S.R.E.Spaltenstein, P.Whitby, F.G.Hill, C.P.Kay, M.S.

(2025) Chem Sci 16: 23342-23350

  • DOI: https://doi.org/10.1039/d5sc06380a
  • Primary Citation of Related Structures:  
    9PUA, 9PUB

  • PubMed Abstract: 

    Streptavidin enjoys numerous biotechnological applications due to its extraordinarily high affinity for biotin and the ease of biotinylation of targets through chemical or biological means. However, two main drawbacks limit its use in therapeutic and diagnostic applications: high immunogenicity and endogenous biotin interference. We propose that a mirror-image biotin/streptavidin system could solve these problems due to the minimal immunogenicity of mirror-image (d-) proteins and the expected lower binding affinity between non-natural d-streptavidin and natural d-biotin. To comprehensively address this problem, we first synthesized the l- and d-enantiomers of streptavidin using a three-segment native chemical ligation approach. This synthesis was enabled by temporarily solubilizing an aggregation-prone peptide segment with a Glu-based AlHx 'helping hand' linker. We developed a novel high-efficiency folding protocol and characterized the synthetic proteins by circular dichroism, size-exclusion chromatography, and binding to natural d-(+)-biotin and the mirror-image l-(-)-biotin via isothermal titration calorimetry. We found a 200-million-fold difference in affinity between streptavidin and its matched vs. mismatched biotin enantiomers that renders these systems functionally orthogonal. To gain further insight into how (-)-biotin binds recombinant streptavidin, we solved high-resolution X-ray crystal structures for both the matched and mismatched interactions. This work demonstrates the high degree of stereospecificity of the streptavidin/biotin interaction and the potential utility of a mirror-image biotin/streptavidin system for therapeutic and diagnostic applications.


  • Organizational Affiliation
    • Department of Biochemistry, University of Utah 15 North Medical Drive East, Room 4100 Salt Lake City UT 84112 USA kay@biochem.utah.edu.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
StreptavidinA [auth J],
B [auth K]
127Streptomyces avidiniiMutation(s): 0 
UniProt
Find proteins for P22629 (Streptomyces avidinii)
Explore P22629 
Go to UniProtKB:  P22629
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP22629
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 0.95 Å
  • R-Value Free:  0.145 (Depositor), 0.146 (DCC) 
  • R-Value Work:  0.131 (Depositor), 0.132 (DCC) 
Space Group: I 2 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 46.688α = 90
b = 94.415β = 90
c = 105.14γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
Aimlessdata scaling
XDSdata reduction
PDB_EXTRACTdata extraction
REFMACphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data

  • Released Date: 2025-09-03 
  • Deposition Author(s): Whitby, F.G.

Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesU54 AI170856

Revision History  (Full details and data files)

  • Version 1.0: 2025-09-03
    Type: Initial release
  • Version 1.1: 2026-03-25
    Changes: Database references